NTLAHealthcareMid-Cap
Intellia Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Intellia Therapeutics, Inc. (NTLA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are NTLA insiders buying or selling?
Intellia Therapeutics, Inc. insiders reported 3 open-market buys ($2.5M) and 113 sells ($255.9M) across 116 Form 4 filings — a net selling position of $253.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 6, 2026)
Total Form 4 filings
116
SEC EDGAR
Insider filers
21
Insider buys (3)
$2.5M
Insider sells (113)
$255.9M
Insider sentiment
Net sellingNet insider flow of $253.4M in net selling.
Recent NTLA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Michael P Dube | VP, Chief Accounting Officer | Sale | 2.6K | $16.78 | $44.3K |
| Jul 6, 2026 | Edward J Dulac III | EVP, Chief Financial Officer | Sale | 4.7K | $18.00 | $84.2K |
| Mar 3, 2026 | James Basta | EVP, General Counsel | Sale | 1.2K | $13.78 | $16.7K |
| Mar 3, 2026 | Eliana Clark | EVP, Chief Technical Officer | Sale | 607 | $13.78 | $8.4K |
| Jan 7, 2026 | John M Leonard | President and CEO | Sale | 34.1K | $9.21 | $314.5K |
| Jan 7, 2026 | Birgit C Schultes | EVP, Chief Scientific Officer | Sale | 8.5K | $9.21 | $78.4K |
| Jan 7, 2026 | James Basta | EVP, General Counsel | Sale | 10.4K | $9.21 | $95.8K |
| Jan 7, 2026 | Fred E Cohen | Director | Purchase | 150.0K | $9.35 | $1.4M |
| Jan 7, 2026 | David Lebwohl | EVP, Chief Medical Officer | Sale | 11.9K | $9.21 | $109.6K |
| Jan 7, 2026 | Eliana Clark | EVP, Chief Technical Officer | Sale | 9.5K | $9.21 | $87.6K |
| Jan 7, 2026 | Edward J Dulac III | EVP, Chief Financial Officer | Sale | 6.4K | $9.21 | $58.8K |
| Jan 7, 2026 | Michael P Dube | VP, Chief Accounting Officer | Sale | 3.0K | $9.21 | $27.5K |
| Dec 12, 2025 | John M Leonard | President and CEO | Sale | 88.1K | $9.49 | $836.4K |
| Oct 3, 2025 | Birgit C Schultes | EVP, Chief Scientific Officer | Sale | 31 | $17.38 | $538.78 |
| Oct 3, 2025 | Michael P Dube | VP, Chief Accounting Officer | Sale | 1.9K | $17.38 | $32.5K |
| Aug 22, 2025 | William J Chase | Director | Purchase | 100.0K | $10.03 | $1.0M |
| Jul 25, 2025 | Edward J Dulac III | EVP, Chief Financial Officer | Sale | 7.5K | $14.02 | $104.6K |
| Jul 3, 2025 | Eliana Clark | EVP, Chief Technical Officer | Sale | 1.0K | $9.82 | $10.0K |
| Jul 3, 2025 | Michael P Dube | VP, Chief Accounting Officer | Sale | 2.5K | $9.95 | $24.9K |
| Jul 2, 2025 | Jesse Goodman | Director | Sale | 3.1K | $9.40 | $29.1K |
| May 1, 2025 | Muna Bhanji | Director | Sale | 265 | $8.50 | $2.3K |
| Mar 4, 2025 | Eliana Clark | EVP, Chief Technical Officer | Sale | 679 | $8.99 | $6.1K |
| Mar 4, 2025 | James Basta | EVP, General Counsel | Sale | 2.6K | $8.99 | $23.1K |
| Jan 31, 2025 | Muna Bhanji | Director | Sale | 265 | $9.97 | $2.6K |
| Jan 7, 2025 | Michael P Dube | VP, Chief Accounting Officer | Sale | 1.4K | $12.18 | $16.7K |
Showing the 25 most recent of 116 Form 4 filings for Intellia Therapeutics, Inc..
Most active NTLA insiders
- John M Leonard23 filings
- Jose E Rivera13 filings
- Eliana Clark11 filings
- David Lebwohl10 filings
- FORMELA JEAN FRANCOIS9 filings
Ask anything about NTLA insider activity
Use Trabud's AI agent to query Intellia Therapeutics, Inc.'s Form 4 history in plain English — "Show me NTLA CEO purchases this year" or compare it against any other ticker.
Open the AI agentNTLA insider trading FAQ
Are Intellia Therapeutics, Inc. insiders buying or selling?
Across 116 SEC Form 4 filings, Intellia Therapeutics, Inc. (NTLA) insiders reported 3 open-market purchases totaling $2.5M and 113 sales totaling $255.9M. That is a net selling position of $253.4M.
How many insiders trade NTLA stock?
21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Intellia Therapeutics, Inc.. The most recent filing was accepted on Jul 6, 2026.
Where does Trabud get NTLA insider trading data?
All NTLA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.